480 related articles for article (PubMed ID: 14557470)
41. Identification of the first PAR1 deletion encompassing upstream SHOX enhancers in a family with idiopathic short stature.
Benito-Sanz S; Aza-Carmona M; Rodríguez-Estevez A; Rica-Etxebarria I; Gracia R; Campos-Barros A; Heath KE
Eur J Hum Genet; 2012 Jan; 20(1):125-7. PubMed ID: 22071895
[TBL] [Abstract][Full Text] [Related]
42. SHOX intragenic microsatellite analysis in patients with short stature.
Ezquieta B; Cueva E; Oliver A; Gracia R
J Pediatr Endocrinol Metab; 2002 Feb; 15(2):139-48. PubMed ID: 11874178
[TBL] [Abstract][Full Text] [Related]
43. SHOX haploinsufficiency and its modifying factors.
Ogata T
J Pediatr Endocrinol Metab; 2002 Dec; 15 Suppl 5():1289-94. PubMed ID: 12510982
[TBL] [Abstract][Full Text] [Related]
44. The phenotype of short stature homeobox gene (SHOX) deficiency in childhood: contrasting children with Leri-Weill dyschondrosteosis and Turner syndrome.
Ross JL; Kowal K; Quigley CA; Blum WF; Cutler GB; Crowe B; Hovanes K; Elder FF; Zinn AR
J Pediatr; 2005 Oct; 147(4):499-507. PubMed ID: 16227037
[TBL] [Abstract][Full Text] [Related]
45. [From gene to disease; from SHOX to Lèri-Weill dyschondrosteosis, Turner syndrome and idiopathic short stature].
Kant SG; Drop SL
Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1456-9. PubMed ID: 11503314
[TBL] [Abstract][Full Text] [Related]
46. Microdeletion in the SHOX 3' region associated with skeletal phenotypes of Langer mesomelic dysplasia in a 45,X/46,X,r(X) infant and Leri-Weill dyschondrosteosis in her 46,XX mother: implication for the SHOX enhancer.
Fukami M; Okuyama T; Yamamori S; Nishimura G; Ogata T
Am J Med Genet A; 2005 Aug; 137(1):72-6. PubMed ID: 16007631
[TBL] [Abstract][Full Text] [Related]
47. Identification of the first de novo PAR1 deletion downstream of SHOX in an individual diagnosed with Léri-Weill dyschondrosteosis (LWD).
Barroso E; Benito-Sanz S; Belinchón A; Yuste-Checa P; Gracia R; Aragones A; Campos-Barros A; Heath KE
Eur J Med Genet; 2010; 53(4):204-7. PubMed ID: 20412871
[TBL] [Abstract][Full Text] [Related]
48. New roles of SHOX as regulator of target genes.
Rappold GA; Durand C; Decker E; Marchini A; Schneider KU
Pediatr Endocrinol Rev; 2012 May; 9 Suppl 2():733-8. PubMed ID: 22946287
[TBL] [Abstract][Full Text] [Related]
49. Usefulness of MLPA in the detection of SHOX deletions.
Funari MF; Jorge AA; Souza SC; Billerbeck AE; Arnhold IJ; Mendonca BB; Nishi MY
Eur J Med Genet; 2010; 53(5):234-8. PubMed ID: 20538086
[TBL] [Abstract][Full Text] [Related]
50. Bone geometry and volumetric bone density at the radius in patients with isolated SHOX deficiency.
Soucek O; Lebl J; Zapletalova J; Novotna D; Plasilova I; Kolouskova S; Zemkova D; Rocek M; Hlavka Z; Hirschfeldova K; Sumnik Z
Exp Clin Endocrinol Diabetes; 2013 Feb; 121(2):109-14. PubMed ID: 23426705
[TBL] [Abstract][Full Text] [Related]
51. SHOX far-downstream copy-number variations involving cis-regulatory nucleotide variants in two sisters with Leri-Weill dyschondrosteosis.
Ogushi K; Muroya K; Shima H; Jinno T; Miyado M; Fukami M
Am J Med Genet A; 2019 Sep; 179(9):1778-1782. PubMed ID: 31228230
[TBL] [Abstract][Full Text] [Related]
52. A novel class of Pseudoautosomal region 1 deletions downstream of SHOX is associated with Leri-Weill dyschondrosteosis.
Benito-Sanz S; Thomas NS; Huber C; Gorbenko del Blanco D; Aza-Carmona M; Crolla JA; Maloney V; Rappold G; Argente J; Campos-Barros A; Cormier-Daire V; Heath KE
Am J Hum Genet; 2005 Oct; 77(4):533-44. PubMed ID: 16175500
[TBL] [Abstract][Full Text] [Related]
53. Radiological signs of Leri-Weill dyschondrosteosis in Turner syndrome.
Binder G; Fritsch H; Schweizer R; Ranke MB
Horm Res; 2001; 55(2):71-6. PubMed ID: 11509862
[TBL] [Abstract][Full Text] [Related]
54. Epidemiology of SHOX deficiency.
Nicolosi A; Caruso-Nicoletti M
J Endocrinol Invest; 2010 Jun; 33(6 Suppl):7-10. PubMed ID: 21057178
[TBL] [Abstract][Full Text] [Related]
55. The sitting height/height ratio for age in healthy and short individuals and its potential role in selecting short children for SHOX analysis.
Malaquias AC; Scalco RC; Fontenele EG; Costalonga EF; Baldin AD; Braz AF; Funari MF; Nishi MY; Guerra-Junior G; Mendonca BB; Arnhold IJ; Jorge AA
Horm Res Paediatr; 2013; 80(6):449-56. PubMed ID: 24296787
[TBL] [Abstract][Full Text] [Related]
56. Quantitative real-time polymerase chain reaction (RQ-PCR) for the rapid detection of SHOX haploinsufficiency in Leri-Weill Syndrome.
Tan YM; Loke KY
Diagn Mol Pathol; 2005 Dec; 14(4):247-9. PubMed ID: 16319696
[TBL] [Abstract][Full Text] [Related]
57. Prevalence of SHOX haploinsufficiency among short statured children.
Marstrand-Joergensen MR; Jensen RB; Aksglaede L; Duno M; Juul A
Pediatr Res; 2017 Feb; 81(2):335-341. PubMed ID: 27814343
[TBL] [Abstract][Full Text] [Related]
58. Novel heterozygous mutation in the SHOX gene leading to familial idiopathic short stature: A case report and literature review.
Liu L; Li J; Li J; Hu H; Liu J; Tang P
Medicine (Baltimore); 2023 Oct; 102(41):e35471. PubMed ID: 37832088
[TBL] [Abstract][Full Text] [Related]
59. Skeletal features and growth patterns in 14 patients with haploinsufficiency of SHOX: implications for the development of Turner syndrome.
Kosho T; Muroya K; Nagai T; Fujimoto M; Yokoya S; Sakamoto H; Hirano T; Terasaki H; Ohashi H; Nishimura G; Sato S; Matsuo N; Ogata T
J Clin Endocrinol Metab; 1999 Dec; 84(12):4613-21. PubMed ID: 10599728
[TBL] [Abstract][Full Text] [Related]
60. Pseudoautosomal inheritance of Léri-Weill syndrome: what does it mean?
Evers C; Heidemann PH; Dunstheimer D; Schulze E; Haag C; Janssen JW; Fischer C; Jauch A; Moog U
Clin Genet; 2011 May; 79(5):489-94. PubMed ID: 20681991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
